Fighting Superbugs: A Clear Hospital Playbook for Saudi Antimicrobial Resistance Stewardship

Signals of antimicrobial pressure show up in different care settings. In Makkah-region public hospitals, a point-prevalence survey found that 61.9% of 710 hospitalized patients were receiving at least one antimicrobial agent. In the private outpatient setting, a claims-based analysis of privately insured beneficiaries in Saudi Arabia reported overall antibiotic consumption of 11.63 defined daily doses (DDD) per 1000 insured persons per day, and mean treatment durations ranging from 8–14 days. The same study notes these durations exceeded global stewardship recommendations. Together, these findings point to a practical stewardship priority: reduce unnecessary exposure and shorten avoidable duration where evidence supports it.

A Hospital Stewardship Playbook Built for Saudi Systems

A workable Saudi hospital playbook starts with policy alignment, then builds infrastructure that makes good prescribing the default. Saudi AMR policy milestones include a Ministry of Health National Action Plan launched in 2017 and updated in 2022, described as including stringent regulations on antibiotic prescriptions, mandatory antimicrobial susceptibility testing, and mandated infection control protocols across healthcare facilities. A One Health-oriented plan is also described as renewed for 2022–2025. At the hospital level, the MOH multicenter surveillance analysis calls out persistent gaps that leaders can operationalize into a to-do list: restricted-antibiotic dispensing, optimization interventions, therapeutic drug monitoring (TDM), and inter-hospital variation. These are measurable, and they are actionable.

Next, strengthen the people-and-process layer that determines whether policies reach the bedside. A 2025 cross-sectional study of 236 healthcare professionals in Saudi Arabia found that 85.2% were aware of AMR, yet 64.1% reported limited access to infection control policies. Daily antibiotic prescribing, dispensing, or administration was reported by 57.6%. Barriers to appropriate prescribing included time constraints (84.7%) and diagnostic uncertainty (75.8%). Only 20.3% used clinical guidelines, while 35.2% relied on pharmaceutical industry materials. In the same study, ASP training improved knowledge scores by 1.6 points, supporting targeted training tied to local guidelines, faster decision support, and feedback on prescribing choices.

Finally, connect stewardship to diagnostics and infection prevention and control (IPC), and treat measurement as a core clinical tool. A Saudi strategy review emphasizes that a combination of stewardship and diagnostics is crucial to prevent transmission and selection of resistant pathogens, and notes that concurrent IPC and stewardship has been shown to reduce healthcare-associated infections, antimicrobial consumption, and transmission of resistant organisms within hospitals. For Saudi antimicrobial resistance stewardship to mature, the MOH multicenter study recommends going further by linking stewardship indicators with clinical outcomes, AMR trends, and patient safety. That closes the loop: hospitals can benchmark restricted-drug compliance, track physician acceptance of recommendations, and standardize feedback so variation narrows over time.